This year’s SCOPE was amazing and well attended with over 3100 people coming from around the globe representing sponsors, CROs, suppliers, consultants and most importantly patients. Coming off last year where there was a fraction of…
Underrepresentation of minorities in clinical research leads to issues such as health disparities, lack of trust in the medical system, limited access to new treatments and inaccurate treatment recommendations for those populations. So, it is important…
As part of the latest v6.0 release of TrialX iConnect we have launched a new Volunteer Search and Outreach module. We are excited about how this module can help study teams to engage registered volunteers by…
👨🏻💼FROM THE CEO’s DESK “As we wrap up 2022, we are pleased to see 12 million+ actions taken by patients, researchers and study sponsors across all our platforms to support clinical research. This includes hundreds of…
With 7.5+ billion people across the globe, humans come in various hues. And while we have a lot in common, we are unique in genetics, food habits, race, ethnicity, culture and language among many others. In…
Diversity in clinical trials is crucial to understanding the effectiveness of drugs in different ethnic populations. The inclusion of participants from different races and ethnicity also ensures the generalization of the result and helps achieve health…
The lack of racial and ethnic diversity among clinical trial participants is a critical problem in medical research in the United States — a weakness exposed quite starkly by the COVID pandemic and the resulting national…
